Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Dulaglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-12) Peptide-Human Igg4 Fc Fusion Protein targeting GLP-1/GLP-1-R/GLP-1R |
|---|---|
| INN Name | dulaglutide |
| Target | GLP1R |
| Format | Peptide Protein fusion |
| Derivation | Human |
| Species Reactivity | Human |
| CH1 Isotype | Fusion – [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 – IGHG4 Fc (Fragment constant) |
| VD LC | Fusion – [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 – IGHG4 Fc (Fragment constant) |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | Eli?Lilly (Indianapolis IN USA) |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | GLP1R |
| Package |
